Production of multiple cytokines and induction of cachexia in athymic nude mice by a new anaplastic thyroid carcinoma cell line.

An anaplastic thyroid cancer cell line, Thena, was recently established in our laboratory following radical thyroidectomy of a patient with anaplastic thyroid cancer. Microscopically, Thena cells were spindle-shaped or small round cells. Thena cells were reactive with cytokeratin AE1/AE3 antibodies, epithelial membrane antigen, interleukin (IL)-6, epithelial growth factor receptor, transforming growth factor (TGF)-alpha, vascular endothelial growth factor, and vimentin. Thena cells secreted high levels of IL-6, leukemia inhibitor factor (LIF), tumor necrosis factor (TNF)-alpha, and TGF-beta1 in the culture supernatants, as determined by enzyme-linked immunosorbent assay. When subcutaneously injected with Thena cells, athymic nude mice developed tumor masses in the skin within 2 weeks. Furthermore, Thena cells induced cachexia in these tumor-bearing mice. High levels of human IL-6, LIF and TGF-beta1 were detected in the mouse sera. To our knowledge, the Thena cell line is the first thyroid cancer cell line reported to induce cachexia in nude mice. This cachectic animal model is worthy of further study to explore the treatment of thyroid cancer-induced cachexia.

[1]  K. Rubin,et al.  Collagen type I expression in experimental anaplastic thyroid carcinoma: Regulation and relevance for tumorigenicity , 2002, International journal of cancer.

[2]  M. Stack,et al.  Tumor production of angiostatin is enhanced after exposure to TNF‐α , 2002, International journal of cancer.

[3]  A. Hirasawa,et al.  Neutrophilia associated with anaplastic carcinoma of the thyroid: production of macrophage colony-stimulating factor (M-CSF) and interleukin-6. , 2000, Thyroid : official journal of the American Thyroid Association.

[4]  B. Westermark,et al.  Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells. , 2000, Experimental cell research.

[5]  J. Kurebayashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society All-Trans-Retinoic Acid Modulates Expression Levels of Thyroglobulin and Cytokines in a New Human Poorly Differentiated Papillary Thyroid Carcin , 2022 .

[6]  J. D. Lin,et al.  The roles of cytokines and retinoic acid in the regulation of human thyroid cancer cell growth. , 1998, Cytokine.

[7]  G. Fontanini,et al.  Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  D. Lazzereschi,et al.  Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein. , 1997, Cancer research.

[9]  W. Scherbaum,et al.  Expression of tumour necrosis factor‐alpha (TNF‐α) mRNA and protein in pathological thyroid tissue and carcinoma cell lines , 1996, Clinical and experimental immunology.

[10]  J. Blaydes,et al.  Loss of responsiveness to transforming growth factor β (TGFβ) is tightly linked to tumorigenicity in a model of thyroid tumour progression , 1996 .

[11]  J. Blaydes,et al.  Loss of responsiveness to transforming growth factor beta (TGFbeta) is tightly linked to tumorigenicity in a model of thyroid tumour progression. , 1996, International journal of cancer.

[12]  T. Le bricon.  Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft. , 1996, Clinical nutrition.

[13]  H. Ishitsuka,et al.  Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  M. Miyata,et al.  Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin‐6 , 1995, International journal of cancer.

[15]  Y. Akiyama,et al.  Cytokine Production in Five Tumor Cell Lines with Activity to Induce Cancer Cachexia Syndrome in Nude Mice , 1995, Japanese journal of cancer research : Gann.

[16]  H. Ishitsuka,et al.  Establishment and characterization of cachexia‐inducing and ‐non‐inducing clones of murine colon 26 carcinoma , 1995, International journal of cancer.

[17]  M. Vitale,et al.  Retinoic acid induces intercellular adhesion molecule-1 hyperexpression in human thyroid carcinoma cell lines. , 1995, The Journal of clinical endocrinology and metabolism.

[18]  O. Nilsson,et al.  Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours , 1995, International journal of cancer.

[19]  D. Fraker,et al.  Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes. , 1994, Cytokine.

[20]  M. Santoro,et al.  Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers , 1994, Cancer.

[21]  D. Haugen,et al.  Demonstration of a TGF‐α‐EGF‐receptor autocrine loop and c‐myc protein over‐expression in papillary thyroid carcinomas , 1993 .

[22]  P. Lampertico.  Anaplastic (sarcomatoid) carcinoma of the thyroid gland. , 1993, Seminars in diagnostic pathology.

[23]  L. Akslen,et al.  Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas. , 1993, International journal of cancer.

[24]  R. Nordan,et al.  Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. , 1992, Cancer research.

[25]  W. L. Wong,et al.  Thyroid follicular cells produce interleukin-8. , 1992, The Journal of clinical endocrinology and metabolism.

[26]  K. Abe,et al.  Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. , 1991, Cancer research.

[27]  A. Billiau,et al.  Severe cachexia in mice inoculated with interferon‐γ‐producing tumor cells , 1991 .

[28]  J. Niloff,et al.  Tumor necrosis factor expression by human ovarian carcinoma in vivo. , 1991, Cancer research.

[29]  G. Wilding,et al.  Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. , 1991, Cancer research.

[30]  L. Bonewald,et al.  Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice. , 1991, The Journal of clinical investigation.

[31]  L. Moldawer,et al.  Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. , 1991, Cancer research.

[32]  B. Estour,et al.  Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1) , 1989, Virchows Archiv. B, Cell pathology including molecular pathology.

[33]  J. Fransson,et al.  Epidermal Growth , 1988, International journal of dermatology.